RFC
OSIR

Regions Financial Corp’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Regions Financial Corp’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-20,915
Closed -$211K – 1132
2013
Q2 		$211K Buy
+20,915
New +$220K ﹤0.01% 996

Other funds holding OSIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Regions Financial Corp's OSIR Position: Q3 2013 in Review

Regions Financial Corp sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q3 2013, closing a stake of 20,915 shares — an estimated $211K sold.

Regions Financial Corp first reported a position in OSIR in Q2 2013 and held it in 1 quarter. The position peaked at $211K in Q2 2013. 64 funds tracked by Wall St. Rank hold OSIR as of Q3 2013.

  • Regions Financial Corp reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q3 2013 after selling out during the quarter.
  • Regions Financial Corp sold 20,915 Osiris Therapeutics, Inc. Common Stock shares in Q3 2013, an estimated $211K.
  • Regions Financial Corp first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and held it in 1 quarter.
  • Regions Financial Corp's Osiris Therapeutics, Inc. Common Stock position peaked at $211K in Q2 2013.
  • 64 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q3 2013.

Based on Regions Financial Corp's 13F filing for Q3 2013, filed 18 Oct 2013.